Volume 25, Issue 4 - Medical Education

Patient education in clinical trials and throughout the product lifecycle

Authors: Susan M Harris, Christopher G Kelly

Abstract

Download the full article

References

1. Macquart de Terline D, Hejblum G, Fernandez C, Cohen A, Antignac M. PLoS One. 2016;11(1):e0146927.
2. Feudtner C. What are the goals of patient education? West J Med. 2001;174:173-4.
3. Adams RJ. Improving health outcomes with better patient understanding and education. Risk Manag Health Policy. 2010;3:61-72.
4. Hoving C, Visser A, Mullen PD, van den Borne B. A history of patient education by health professionals in Europe and North America: from authority to shared decision making education. Patient Educ Couns. 2010;78(3):275-81.
5. Powell J, Inglis N, Ronnie J, Large S. The characteristics and motivations of online health information seekers: cross-sectional survey and qualitative interview study. J Med Internet Res. 2011;13(1):e20.
6. Anderson CM. Information therapy: a prescription for the digital era. Health Care Manag (Frederick). 2013;32(3):242-5.
7. Hawkins RP, Kreuter M, Resnicow K, Fishbein M, Dijkstra A. Understanding tailoring in communicating about health. Health Educ Res. 2008;23(3):454-66.
8. Salita JT. Writing for lay audiences: a challenge for scientists. Medical Writing. 2015;24(4):183-9.
9. Gul R B, Ali PA. Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs. 2010;19 (1-2):227-33.
10. Kaur G, Smyth RL, Williamson P. Developing a survey of barriers and facilitators to recruitment in randomized controlled trials. Trials. 2012;13:218.
11. Brandberg Y, Johansson H, Bergenmar M. Patients’ knowledge and perceived understanding – associations with consenting to participated in cancer clinical trials. Contemp Clin Trials Comm. 2016;2:6-11.
12. The Center for Information and Study on Clinical Research Participation (CISCRP). Perceptions and Insights Study: Report on ineligible participants and those who terminate participation early. 2013. Available from: https://www.ciscrp.org/download/2013-perceptions-insights-study-ineligibleparticipants-and-those-who-drop-out/?wpdmdl=6650
13. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) E6 Good Clinical Practice: Consolidated guidance. 1996. Available from: http://www.fda.gov/downloads/Drugs/.../Guidances/ucm073122.pdf
14. The World Medical Association. Declaration of Helsinki. 2013 [cited 1 Oct 2016]. Available from: http://www.wma.net/en/30publications/10policies/b3/
15. Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for biomedical research involving human subjects. 2002. Available from: http://www.recerca.uab.es/ceeah/docs/cioms.pdf
16. Council for International Organizations of Medical Sciences (CIOMS). Final draft CIOMS guidelines. Version 10. September 2015. Available from: http://www.cioms.ch/final_draft_CIOMS_guidelines-10_september_2015-with_watermarks.pdf
17. Cartmell KB, Bonilha HS, Matson T, Bryant DC, Zapka J, Bentz TA, et al. Patient participation in cancer clinical trials: a pilot test of lay navigation. Contemp Clin Trials Comm. 2016;3:86-93.
18. Siegal G, Bonnie RJ, Appelbaum PS. Personalized disclosure by information-ondemand: attending to patients’ needs in the informed consent process. J Law Med Ethics. 2012;40(2):359-67.
19. US Food and Drug Administration (FDA). Use of electronic informed consent in clinical investigations. Draft guidance. March 2015. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm436811.pdf
20. European Parliament. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm436811.pdfhttp://ec.europa.eu/health/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf
21. Gillow CL. Layperson summaries of clinical trial results: useful resources in the vacuum of regulatory guidance. Medical Writing. 2015;24(4):205-9.
22. Robben S, van Kempen J, Heinen M, Zuidema S, Olde RIkkert M, Schers H, et al. Preferences for receiving information among frail older adults and their informal caregivers: a qualitative study. Fam Pract. 2012;29(6):742-7.
23. Hirsch O, Keller H, Krones T, Donner- Banzhoff N. arriba-lib: evaluation of an electronic library of decision aids in primary care physicians. BMC Med Inform Decis Mak. 2012 Jun 6;12:48.
24. European Patients’ Forum. Patient Empowerment Campaign. 2015 [cited 1 Oct 2016]. Available from: www.eupatient.eu/campaign/PatientsprescribE
25. European Patients’ Forum. Improving the sustainability of healthcare systems through better adherence to therapies: a multistakeholder approach. Background briefing. 2011 [cited 1 Oct 2016]. Available from: http://www.eu-patient.eu/globalassets/policy/adherence-compliance-concordance/adherence–joint-briefing-paper.pdf
26. Miller TA. Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis. Patient Educ Couns. 2016;99(7):1079-86.
27. Matsumaya RK, Kuhn LA, Molisani A, Wilson-Genderson MC. Cancer patients’ information needs the first nine months after diagnosis. Patient Educ Couns. 2013;90(1):96-102.
28. Prochaska JO, DiClemente CC. Stages and processes of self-change in smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–5.
29. Prochaska JO. Assessing how people change. Cancer. 1991;67(3 Suppl):805-7.
30. Medicines and Healthcare Products Regulatory Agency (MHRA). Disease Awareness Campaign Guidelines: Appendix 7. 2012 Jul. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/407290/Appendix_7_-_Blue_Guide.pdf
31. The Association of the British Pharmaceutical Industry (ABPI). Guidance notes for patient safety and pharmacovigilance in patient support programmes. 2011 [cited 1 Oct 2016]. Available from: http://www.abpi.org.uk/our-work/library/guidelines/Pages/patient-safety-pharmacovigilance-.aspx
32. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Simply put – a guide for creating easy to understand materials. 2010. Available from: http://www.cdc.gov/healthliteracy/pdf/Simply_Put.pdf
33. Dale E. Audiovisual Methods in Teaching. 3rd ed. New York: Holt, Rinehart & Winston; 1969:108.
34. Giuse NB, Koonce TY, Storrow AB, Kusnoor SV, Ye F. Using health literacy and learning style preferences to optimise the delivery of health information. J Health Commun. 2012;17(Suppl 3): 122-40.
35. Walsh E, Sheridan A. Factors affecting patient participation in clinical trials in Ireland: a narrative review. Contemp Clin Trials Comm. 2016;3:23-31.
36. US Food and Drug Administration (FDA). Recruiting Study Subjects – Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators. 2016 [cited 1 Oct 2016]. Available from: http://www.fda.gov/RegulatoryInformation/Guidances/ucm126428.htm
37. World Self-Medication Industry (WSMI). Advertising of non-prescription medicines to the public. 2008. Available from: http://www.wsmi.org/wp-content/data/pdf/wsmi_brochureadvertising.pdf